Compared with chemo alone, CKI combined with chemo effectively improved thrombocytopenia in patients with NSCLC (RR = 0.60, 95% CI: 0.49 to 0.73; P < 0.00001) (Figure 5). The gene discussed is CHKA; the disease is Thrombocytopenia.